Supernus Pharmaceuticals Inc to Acquire the CNS portfolio of Us WorldMeds LLC - Conference Call Transcript
Good morning, ladies and gentlemen, and welcome to the Supernus Pharmaceuticals Conference Call.
(Operator Instructions)
As a reminder, this conference call is being recorded. I would now like to turn the conference over to Peter Vozzo of Westwicke, Investor Relations representative for Supernus Pharmaceuticals. You may begin.
Thank you, Chris. Good morning, everyone, and thank you for joining us today for Supernus Pharmaceuticals conference call to discuss the acquisition of the CNS products of US WorldMeds, which was announced last night. On the call with me today are Supernus' Chief Executive Officer, Jack Khattar; Chief Financial Officer, Greg Patrick; and Vice President, Corporate Development, Bryan Roecklein. Today's call and associated slides are being made available via the Investor Relations section of the company's website at ir.supernus.com.
Following remarks by management, we will open the call to questions. During the course of this call, management may make certain forward
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
